Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins
- Written by Reporters
Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio
HONG KONG SAR - Media OutReach Newswire - 14 May 2025 - Bora Pharmaceuticals (TWSE: 6472) today announced its financial results and operational highlights for first quarter of 2025.Quarterly Business and Financial Highlights...

